Literature DB >> 23279980

Multifocal breast cancer documented in large-format histology sections: long-term follow-up results by molecular phenotypes.

Gyula Pekar1, Syster Hofmeyer, László Tabár, Miklós Tarján, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Sherry Yueh-Hsia Chiu, Dan Hellberg, Mária Gere, Tibor Tot.   

Abstract

BACKGROUND: The prognostic significance of molecular phenotype in breast cancer is well established in the literature. Recent studies have demonstrated that subgross lesion distribution (unifocal, multifocal, and diffuse) and disease extent also carry prognostic significance in this disease. However, the correlation of molecular phenotypes with subgross parameters has not yet been investigated in detail.
METHODS: In total, 444 consecutive invasive breast cancers that were documented in large-format histology slides and worked up with detailed radiologic-pathologic correlation were sampled into tissue microarray blocks and stained immunohistochemically to delineate the molecular subtypes.
RESULTS: Diffuse or multifocal distribution of the invasive component of breast carcinomas in this series was associated with a 4.14-fold respectively 2.75-fold risk of cancer-related death compared with unifocal tumors irrespective of molecular phenotype. Patients who had human epidermal growth factor receptor 2 (HER2)-positive cancers; estrogen receptor-negative, progesterone receptor-negative, and HER2-negative (triple-negative) cancers; or basal-like cancers had a 2.18-fold, 2.33-fold, and 4.07-fold risk of dying of disease, respectively, compared with patients who had luminal A carcinomas. Unifocal luminal A, HER2-positive, and basal-like cancers were associated with significantly better long-term survival outcomes than their multifocal or diffuse counterparts; luminal B and triple-negative tumors also had the same tendency. In multivariate analysis, patient age, tumor size category, lymph node status, lesion distribution, and molecular phenotypes remained significant.
CONCLUSIONS: Multifocality and diffuse distribution of the invasive component were associated with significantly poorer survival in women with breast carcinomas compared with unifocal disease in patients with luminal A, HER2 type, and basal-like cancers. Molecular classification of breast cancer is a powerful tool but gains in power when combined with conventional and subgross morphologic parameters.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23279980     DOI: 10.1002/cncr.27877

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

Review 1.  Hepatic Metastasis from Breast Cancer.

Authors:  Ariel N Liberchuk; Amy R Deipolyi
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

Review 2.  Is breast conservative surgery a reasonable option in multifocal or multicentric tumors?

Authors:  Gilles Houvenaeghel; Agnès Tallet; Aurélie Jalaguier-Coudray; Monique Cohen; Marie Bannier; Camille Jauffret-Fara; Eric Lambaudie
Journal:  World J Clin Oncol       Date:  2016-04-10

3.  Clinical implications of multifocality as a prognostic factor in breast carcinoma - a multivariate analysis study comprising 460 cases.

Authors:  Monica Boros; Septimiu Voidazan; Cosmin Moldovan; Rares Georgescu; Cornelia Toganel; Denisa Moncea; Claudiu V Molnar; Cristian Podoleanu; Alexandru Eniu; Simona Stolnicu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 4.  Mathematical models of breast and ovarian cancers.

Authors:  Dana-Adriana Botesteanu; Stanley Lipkowitz; Jung-Min Lee; Doron Levy
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-06-03

5.  Diffuse invasive breast carcinoma of no special type.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2015-10-31       Impact factor: 4.064

6.  Uncovering the genomic heterogeneity of multifocal breast cancer.

Authors:  Christine Desmedt; Debora Fumagalli; Elisabetta Pietri; Gabriele Zoppoli; David Brown; Serena Nik-Zainal; Gunes Gundem; Françoise Rothé; Samira Majjaj; Anna Garuti; Enrico Carminati; Sherene Loi; Thomas Van Brussel; Bram Boeckx; Marion Maetens; Laura Mudie; Delphine Vincent; Naima Kheddoumi; Luigi Serra; Ilaria Massa; Alberto Ballestrero; Dino Amadori; Roberto Salgado; Alexandre de Wind; Diether Lambrechts; Martine Piccart; Denis Larsimont; Peter J Campbell; Christos Sotiriou
Journal:  J Pathol       Date:  2015-05-07       Impact factor: 7.996

7.  Delayed presentation of inflammatory breast carcinoma during the COVID-19 pandemic.

Authors:  Daniele Bernardi; Emanuele Asti; Giulia Bonavina; Alberto Luporini; Claudio Clemente; Luigi Bonavina
Journal:  Eur Surg       Date:  2021-06-15       Impact factor: 0.796

8.  Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology.

Authors:  Tobias Weissenbacher; Eva Hirte; Christina Kuhn; Wolfgang Janni; Doris Mayr; Uwe Karsten; Brigitte Rack; Klaus Friese; Udo Jeschke; Sabine Heublein; Darius Dian; Nina Ditsch
Journal:  BMC Cancer       Date:  2013-07-26       Impact factor: 4.430

9.  Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.

Authors:  Nadine Norton; Pooja P Advani; Daniel J Serie; Xochiquetzal J Geiger; Brian M Necela; Bianca C Axenfeld; Jennifer M Kachergus; Ryan W Feathers; Jennifer M Carr; Julia E Crook; Alvaro Moreno-Aspitia; Panos Z Anastasiadis; Edith A Perez; E Aubrey Thompson
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

10.  Value of Machine Learning with Multiphases CE-MRI Radiomics for Early Prediction of Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Invasive Breast Cancer.

Authors:  Qin Li; Qin Xiao; Jianwei Li; Zhe Wang; He Wang; Yajia Gu
Journal:  Cancer Manag Res       Date:  2021-06-28       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.